January 5, 2010 - Breast cancer screening should begin at age 40 and earlier in high-risk patients, according to the new recommendations from the Society of Breast Imaging (SBI) and the American College of Radiology (ACR) on breast cancer screening, published in the January issue of the Journal of the American College of Radiology (JACR). The recommendations also suggest appropriate utilization of medical imaging modalities such as mammography, magnetic resonance imaging (MRI), and ultrasound for breast cancer screening. “The significant decrease in breast cancer mortality, which amounts to nearly 30 percent since 1990, is a major medical success and is due largely to earlier detection of breast cancer through mammography screening,” said Carol H. Lee, MD. “For women with the highest risk of developing breast cancer, screening technologies in addition to mammography have been adopted,” said Dr. Lee. The new recommendations released by the SBI and ACR include recommendations for imaging screening for breast cancer by imaging technique (mammography, MRI, and ultrasound) and by risk factor. The recommendations state that the average patient should begin annual breast cancer screening at age 40. High-risk patients should begin by age 30, but not before 25. “Evidence to support the recommendation for regular periodic screening mammography comes from the results of several randomized trials (RCTs) conducted in Europe and North America that included a total of nearly 500,000 women. Overall, based on a meta-analysis of the RCTs, there was a 26 percent reduction in mortality,” said Dr. Lee. “It should be remembered that mammography is the only imaging modality that has been proven to decrease mortality from breast cancer. However major efforts continue to build on this success by developing additional methods to screen for early breast cancer,” she said. Dr. Lee stressed that the SBI and ACR "wish to remind women and their physicians that in those instances in which there is a concern that risk of developing cancer is considerably elevated from that of the general population, consultation with appropriate experts in breast cancer genetics and/or high risk management is desirable.” For more information: www.jacr.org
If you enjoy this content, please share it with a colleague
Related Content
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...
May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...
May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...
May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...
Decades since the advent of breast scanning technology, innovations in noninvasive diagnostic imaging provide new ...
Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...
May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...
May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...
April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement ...